Literature DB >> 1551016

Equine piroplasmosis: a review.

D T de Waal1.   

Abstract

This review focuses on equine piroplasmosis with specific reference to its distribution, diagnosis and clinical and pathological signs. The more common used drugs are discussed both with reference to treatment and chemosterilization. Areas requiring further research are also briefly mentioned.

Entities:  

Mesh:

Year:  1992        PMID: 1551016     DOI: 10.1016/0007-1935(92)90061-5

Source DB:  PubMed          Journal:  Br Vet J        ISSN: 0007-1935


  36 in total

1.  Subclinical leptospirosis may impair athletic performance in racing horses.

Authors:  Camila Hamond; Gabriel Martins; Walter Lilenbaum
Journal:  Trop Anim Health Prod       Date:  2012-05-02       Impact factor: 1.559

Review 2.  Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.

Authors:  Wesley C Van Voorhis; J Stone Doggett; Marilyn Parsons; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Michael W Riggs; Andrew Hemphill; Daniel K Howe; Robert H Mealey; Audrey O T Lau; Ethan A Merritt; Dustin J Maly; Erkang Fan; Kayode K Ojo
Journal:  Exp Parasitol       Date:  2017-01-05       Impact factor: 2.011

3.  First molecular evidence of Babesia caballi and Theileria equi infections in horses in Cuba.

Authors:  Adrian Alberto Díaz-Sánchez; Marcus Sandes Pires; Carlos Yrurzun Estrada; Ernesto Vega Cañizares; Sergio Luis Del Castillo Domínguez; Alejandro Cabezas-Cruz; Evelyn Lobo Rivero; Adivaldo Henrique da Fonseca; Carlos Luiz Massard; Belkis Corona-González
Journal:  Parasitol Res       Date:  2018-07-23       Impact factor: 2.289

4.  Theileria equi and Babesia caballi infection of equids in Punjab, India: a serological and molecular survey.

Authors:  Deepak Sumbria; Lachhman Das Singla; Amrita Sharma
Journal:  Trop Anim Health Prod       Date:  2015-09-19       Impact factor: 1.559

5.  Serum antibodies from a subset of horses positive for Babesia caballi by competitive enzyme-linked immunosorbent assay demonstrate a protein recognition pattern that is not consistent with infection.

Authors:  Peter O Awinda; Robert H Mealey; Laura B A Williams; Patricia A Conrad; Andrea E Packham; Kathryn E Reif; Juanita F Grause; Angela M Pelzel-McCluskey; Chungwon Chung; Reginaldo G Bastos; Lowell S Kappmeyer; Daniel K Howe; SallyAnne L Ness; Donald P Knowles; Massaro W Ueti
Journal:  Clin Vaccine Immunol       Date:  2013-09-18

6.  Detection and molecular characterization of Babesia caballi and Theileria equi isolates from endemic areas of Brazil.

Authors:  Alexandra Heim; Lygia M F Passos; Múcio F B Ribeiro; Lívio M Costa-Júnior; Camila V Bastos; Dagmar D Cabral; Jörg Hirzmann; Kurt Pfister
Journal:  Parasitol Res       Date:  2007-09-09       Impact factor: 2.289

7.  Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.

Authors:  O Nicolas Schwint; Massaro W Ueti; Guy H Palmer; Lowell S Kappmeyer; Melissa T Hines; R Timothy Cordes; Donald P Knowles; Glen A Scoles
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  Prevalence of Theileria equi, Babesia caballi, and Anaplasma phagocytophilum in horses from the north of Portugal.

Authors:  Ana J Ribeiro; Luís Cardoso; José M Maia; Teresa Coutinho; Mário Cotovio
Journal:  Parasitol Res       Date:  2013-04-17       Impact factor: 2.289

9.  Comparative efficacy of diminazene diaceturate and diminazene aceturate for the treatment of babesiosis in horses.

Authors:  Hamad Bin Rashid; Mamoona Chaudhry; Haroon Rashid; Khalid Pervez; Muhammad Arif Khan; Asim Khalid Mahmood
Journal:  Trop Anim Health Prod       Date:  2007-12-15       Impact factor: 1.559

10.  Parasitological and molecular diagnostic of a clinical Babesia caballi outbreak in Southern Romania.

Authors:  Mariana Ionita; Isabela Madalina Nicorescu; Kurt Pfister; Ioan Liviu Mitrea
Journal:  Parasitol Res       Date:  2018-05-15       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.